Table 3.
Characteristics of patients on two drug class antihypertensive therapy by comorbidity
| Patient characteristics | Comorbidity | ||
|---|---|---|---|
| Post-MI | Diabetes | Uncomplicateda | |
| n = 1,582 | n = 4,746 | n = 4,690 | |
| Age | 65.3 ± 12.1 | 62.1 ± 12.8 | 57.9 ± 14.1 |
| Male | 930 (59) | 2,104 (44) | 1,803 (38) |
| BMI, kg/m2 | 29.9 ± 6.6 | 32.8 ± 7.6 | 31.5 ± 7.4 |
| Ethnicity | |||
| White | 1,253 (79) | 3,156 (66) | 3,472 (74) |
| African American | 254 (16) | 1,297 (27) | 930 (20) |
| Other | 70 (4) | 264 (6) | 245 (5) |
| Unknown | 5 (1) | 29 (1) | 43 (1) |
| Hispanic | 42 (3) | 171 (4) | 136 (3) |
| Disease history | |||
| IHD | 1,582 (100) | 2,099 (44) | b |
| MI | 1,582 (100) | 757 (16) | b |
| Diabetes | 757 (48) | 4,746 (100) | b |
| CKD | 701 (44) | 1,713 (36) | b |
| Stroke/TIA | 556 (35) | 1,023 (21) | b |
| Insurance | |||
| Private | 320 (20) | 1,352 (28) | 2,137 (46) |
| Medicaid | 146 (9) | 503 (11) | 387 (8) |
| Medicare | 966 (61) | 2,461 (52) | 1,528 (33) |
| Other | 15 (1) | 64 (1) | 71 (1) |
| Uninsured | 135 (9) | 366 (8) | 567 (12) |
| Baseline SBP | 131.3 ± 18.5 | 134.7 ± 17.5 | 136.9 ± 17.3 |
| Number of drugs | 2.2 ± 1.0 | 2.1 ± 1.0 | 1.7 ± 0.8 |
| Treatment duration, days | 105.8 ± 118.9 | 106.5 ± 119 | 126.4 ± 140.3 |
Number of patients with percentage (%) in parentheses and mean ± SD shown.
Abbreviations: BMI, body mass index; IHD, ischemic heart disease; MI, myocardial infarction; CKD, chronic kidney disease; TIA, transient ischemic attack; BP, blood pressure.
aUncomplicated hypertension defined as lack of IHD, diabetes, CKD, stroke, or TIA.
bNot applicable.